Therapeutic strategy shows potential efficacy for treating high-risk medulloblastoma, indicating a new treatment option.
Our results highlight ONC206 as a novel therapeutic option for patients with high-risk medulloblastoma and provide strong rationale for testing the efficacy of ONC206 in the treatment of these patients.
No takes yet. Share an insight, caveat, or question.
Tzaridis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: